We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.96%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.89B
AUM Growth
+$125M
(+3.3%)
Cap. Flow
-$226M
Cap. Flow
% of AUM
-5.82%
Top 10 Holdings %
Top 10 Hldgs %
15.92%
Holding
230
New
17
Increased
95
Reduced
68
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATMI
A T M I INC
ATMI
|
+$32.5M |
| 2 |
Deckers Outdoor
DECK
|
+$29.6M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$24.2M |
| 4 |
Brinker International
EAT
|
+$21.4M |
| 5 |
GIMO
Gigamon Inc.
GIMO
|
+$19.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$40.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$39M |
| 3 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$37.5M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$31.6M |
| 5 |
BID
Sotheby's
BID
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.66% |
| 2 | Consumer Discretionary | 15.66% |
| 3 | Healthcare | 15.51% |
| 4 | Industrials | 11.08% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
CEVA Inc
CEVA
$1.08B
| $4.29M | 0.11% |
281,557
+7,536
| +3% | +$114K |
|
|
PSEM
177
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
| $4.2M | 0.11% |
474,499
+61,979
| +15% | +$526K |
|
178
JetBlue
JBLU
$2.29B
| $4.18M | 0.11% |
490,000
| – | – |
|
179
Vitamin Cottage Natural Grocers
NGVC
$654M
| $4.04M | 0.1% |
+95,236
| New | +$3.67M |
|
|
BSFT
180
DELISTED
BroadSoft, Inc.
BSFT
| $3.99M | 0.1% |
145,900
+6,920
| +5% | +$205K |
|
181
NeoGenomics
NEO
$2.13B
| $3.73M | 0.1% |
1,031,131
+641,901
| +165% | +$2.23M |
|
|
DGI
182
DELISTED
DigitalGlobe Inc.
DGI
| $3.61M | 0.09% |
87,800
| – | – |
|
|
ENV
183
DELISTED
ENVESTNET, INC.
ENV
| $3.5M | 0.09% |
+86,800
| New | +$3.16M |
|
|
CSH
184
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $3.42M | 0.09% |
196,817
| – | – |
|
185
STAAR Surgical
STAA
$1.21B
| $3.36M | 0.09% |
207,317
+110,447
| +114% | +$1.48M |
|
|
SOHO
186
DELISTED
Sotherly Hotels
SOHO
| $3.23M | 0.08% |
543,080
+157,652
| +41% | +$807K |
|
|
BDSI
187
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.99M | 0.08% |
+507,251
| New | +$2.61M |
|
|
ATW
188
DELISTED
Atwood Oceanics
ATW
| $2.78M | 0.07% |
52,000
-39,000
| -43% | -$2.1M |
|
|
INWK
189
DELISTED
InnerWorkings, Inc.
INWK
| $2.72M | 0.07% |
349,093
-329,603
| -49% | -$2.67M |
|
|
SQI
190
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
| $2.42M | 0.06% |
85,120
-222,880
| -72% | -$5.74M |
|
|
CVGW
191
DELISTED
Calavo Growers
CVGW
| $2.4M | 0.06% |
79,291
+27,731
| +54% | +$825K |
|
|
LF
192
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $2.4M | 0.06% |
+301,700
| New | +$2.56M |
|
|
ZIXI
193
DELISTED
Zix Corporation
ZIXI
| $2.36M | 0.06% |
517,157
+270,757
| +110% | +$1.22M |
|
194
Coherent
COHR
$74.2B
| $2.25M | 0.06% |
128,266
-24,434
| -16% | -$417K |
|
|
PATH
195
DELISTED
NUPATHE INC COM STK
PATH
| $2.12M | 0.05% |
647,614
-536,045
| -45% | -$1.19M |
|
|
SPN
196
DELISTED
Superior Energy Services, Inc.
SPN
| $1.86M | 0.05% |
6,998
-19,962
| -74% | -$5.22M |
|
|
SPA
197
DELISTED
Sparton
SPA
| $1.85M | 0.05% |
66,330
+6,410
| +11% | +$165K |
|
198
Protolabs
PRLB
$2.13B
| $1.84M | 0.05% |
25,815
-36,495
| -59% | -$2.83M |
|
|
ELRC
199
DELISTED
ELECTRO RENT CORP
ELRC
| $1.83M | 0.05% |
99,064
+34,664
| +54% | +$651K |
|
|
BSTG
200
DELISTED
Biostage, Inc. Common Stock
BSTG
| $1.77M | 0.05% |
+372,635
| New | +$1.74M |
|
Similar funds
HBT
BC
SW
WFMPM
AG
TA
ACP
TP
Granahan Investment Management's Q4 2013 Portfolio in Review
As of Q4 2013, Granahan Investment Management held 230 positions worth $3.89B, up 3.3% from $3.76B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Granahan Investment Management withdrew a net $226M in Q4 2013, closing 21 positions and reducing 68 holdings. Its most notable exit was BioMarin Pharmaceuticals, an estimated $40.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Granahan Investment Management opened a new position in Deckers Outdoor worth $33.8M.
- Granahan Investment Management's largest Q4 2013 buy was Deckers Outdoor: 2,399,400 shares worth $33.8M.
- Granahan Investment Management added most to A T M I INC in Q4 2013, an estimated $32.5M increase.
- Granahan Investment Management's biggest Q4 2013 reduction was Sotheby's, cutting an estimated $27.7M.
- Granahan Investment Management fully exited BioMarin Pharmaceuticals in Q4 2013, selling an estimated $40.1M.
- Granahan Investment Management's ten largest holdings make up 16% of its $3.89B portfolio in Q4 2013.
- Granahan Investment Management opened 17 new positions and closed 21 in Q4 2013.
- Granahan Investment Management's portfolio value rose 3.3% quarter-over-quarter to $3.89B.
Based on Granahan Investment Management's 13F filing for Q4 2013, filed 30 Jan 2014.